Tandem Diabetes Care Inc (TNDM)
37.55
+0.50
(+1.35%)
USD |
NASDAQ |
Apr 30, 13:45
Tandem Diabetes Care Enterprise Value: 2.249B for April 29, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 29, 2024 | 2.249B |
| April 26, 2024 | 2.130B |
| April 25, 2024 | 2.151B |
| April 24, 2024 | 2.122B |
| April 23, 2024 | 2.112B |
| April 22, 2024 | 1.900B |
| April 19, 2024 | 1.814B |
| April 18, 2024 | 1.847B |
| April 17, 2024 | 1.901B |
| April 16, 2024 | 1.980B |
| April 15, 2024 | 1.908B |
| April 12, 2024 | 2.016B |
| April 11, 2024 | 2.040B |
| April 10, 2024 | 2.086B |
| April 09, 2024 | 2.107B |
| April 08, 2024 | 2.019B |
| April 05, 2024 | 2.026B |
| April 04, 2024 | 1.994B |
| April 03, 2024 | 2.066B |
| April 02, 2024 | 2.016B |
| April 01, 2024 | 2.039B |
| March 28, 2024 | 2.141B |
| March 27, 2024 | 2.134B |
| March 26, 2024 | 2.028B |
| March 25, 2024 | 1.793B |
| Date | Value |
|---|---|
| March 22, 2024 | 1.803B |
| March 21, 2024 | 1.908B |
| March 20, 2024 | 1.948B |
| March 19, 2024 | 1.839B |
| March 18, 2024 | 1.860B |
| March 15, 2024 | 1.695B |
| March 14, 2024 | 1.655B |
| March 13, 2024 | 1.696B |
| March 12, 2024 | 1.780B |
| March 11, 2024 | 1.756B |
| March 08, 2024 | 1.832B |
| March 07, 2024 | 1.764B |
| March 06, 2024 | 1.594B |
| March 05, 2024 | 1.596B |
| March 04, 2024 | 1.861B |
| March 01, 2024 | 1.627B |
| February 29, 2024 | 1.565B |
| February 28, 2024 | 1.562B |
| February 27, 2024 | 1.611B |
| February 26, 2024 | 1.711B |
| February 23, 2024 | 1.729B |
| February 22, 2024 | 1.458B |
| February 21, 2024 | 1.297B |
| February 20, 2024 | 1.363B |
| February 16, 2024 | 1.420B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
717.62M
Minimum
Nov 10 2023
9.420B
Maximum
Dec 28 2021
4.164B
Average
3.787B
Median
Aug 23 2019
Enterprise Value Benchmarks
| Insulet Corp | 12.62B |
| Stryker Corp | 138.80B |
| Integer Holdings Corp | 4.937B |
| Teleflex Inc | 11.40B |
| Perspective Therapeutics Inc | 955.03M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -30.00M |
| Revenue (Quarterly) | 196.80M |
| Total Expenses (Quarterly) | 231.86M |
| EPS Diluted (Quarterly) | -0.46 |
| Gross Profit Margin (Quarterly) | 47.41% |
| Profit Margin (Quarterly) | -15.25% |
| Earnings Yield | -9.16% |
| Normalized Earnings Yield | -9.161 |